The Belt and Road: Cooperation, Harmony and Win-Win
products

Products

Avanafil Intermediate II CAS:330785-81-4

Avanafil Intermediate II is a chemical compound known for its crucial role in pharmaceutical synthesis, particularly in the production of Avanafil, a medication used for treating erectile dysfunction. This compound is classified as an intermediate in the synthesis pathway of Avanafil and holds significance in medicinal chemistry and drug development.


Product Detail

Product Tags

Application and Effect:

The molecular structure of Avanafil Intermediate II includes a pyrimidine core substituted with functional groups essential for Avanafil's synthesis. These groups contribute to the compound's physicochemical properties, such as solubility, stability, and reactivity, which are vital for pharmaceutical applications. The specific arrangement of these groups enables precise interactions with target molecules during Avanafil synthesis. Synthesis and Applications The synthesis of Avanafil Intermediate II involves multi-step procedures starting from commercially available starting materials. Common synthetic routes may include condensation reactions and subsequent functional group modifications to introduce the necessary substituents onto the pyrimidine core. This intermediate plays a crucial role in the efficient and scalable synthesis of Avanafil, a potent medication for erectile dysfunction. Pharmaceutical Relevance Avanafil Intermediate II's significance lies in its contribution to the pharmaceutical industry's ability to produce Avanafil. Avanafil, as a phosphodiesterase type 5 (PDE5) inhibitor, is widely used for treating erectile dysfunction. The efficient synthesis of Avanafil depends on the quality and availability of intermediates like Avanafil Intermediate II, highlighting its pharmaceutical relevance. Therapeutic Potential While Avanafil Intermediate II itself is not a therapeutic agent, its role in Avanafil synthesis underscores its indirect therapeutic potential. Avanafil, the final product derived from this intermediate, exhibits clinically proven efficacy in treating erectile dysfunction by enhancing erectile function through PDE5 inhibition. Avanafil's therapeutic benefits have been well-established in clinical settings, contributing to improved patient outcomes. Conclusion In conclusion, Avanafil Intermediate II plays a pivotal role in pharmaceutical synthesis, particularly in the production of Avanafil for treating erectile dysfunction. Its specific molecular structure and contributions to Avanafil's synthesis highlight its importance in medicinal chemistry and drug development. As research and advancements in pharmaceutical synthesis continue, Avanafil Intermediate II's role is expected to remain significant, benefiting individuals experiencing erectile dysfunction and advancing pharmaceutical innovation.

Product Sample:

L-Arginine1
L-Arginine2

Product Packing:

L-Arginin3

Additional Information:

Composition C16H18ClN3O3S
Assay 99%
Appearance white powder
CAS No.  330785-81-4
Packing Small and bulk
Shelf Life 2 years
Storage Store in cool and dry area
Certification ISO.

 


  • Previous:
  • Next:

  • Write your message here and send it to us